Dr. Paula Brown, a distinguished member of the Scientific Association for Botanical Education and Research (SABER) Steering Committee and Director of Applied Research at the British Columbia Institute of Technology, recently participated in the Fourth International Kratom Symposium, emphasizing the critical need for scientific clarity and regulatory oversight in the kratom industry.
Dr. Brown, a recognized expert in natural health and food product research, addressed the complexities surrounding kratom, a botanical used traditionally in Southeast Asia and increasingly in the United States for pain relief, and increased focus to SunnySide Supplement Journal. She highlighted the confusion and misinformation in the marketplace, particularly concerning synthetic derivatives like 7-hydroxymitragynine (7-OH). Dr. Brown asserted, “Synthetic 7-OH is not kratom—it is a highly potent, unregulated chemical,” underscoring the potential public health risks associated with such products. (Read the article here.)
The symposium, held in February, brought together leading researchers from institutions such as the University of Florida, Johns Hopkins University, and Universiti Sains Malaysia. Discussions focused on advancing scientific understanding of kratom's safety and efficacy, as well as addressing regulatory challenges. Dr. Brown emphasized the importance of distinguishing between traditional kratom products and synthetic isolates to ensure consumer safety and informed decision-making.
As a member of the SABER Steering Committee, Dr. Brown continues to advocate for evidence-based policies and practices in the natural products industry. Her participation in the symposium reflects SABER's commitment to fostering scientific research and regulatory clarity in emerging sectors.
